SEHK Hosts Two PE-backed BioTech Plays
13 May 2026
US$ 20.00
IMPACT Therapeutics Inc (IMPACT), an oncology drug company backed by Lilly Asia Ventures (LAV) and Decheng Capital ......
Related Publications
KKR & Co Inc, through its private credit and insurance platforms, has made a cornerstone investment in a A$400 m...
MPCi, Fortune Venture Capital and Shenzhen Capital Group were among returning investors in the recently completed ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.